APO Research, Inc.

APO RESEARCH · REPORT

Integrated Precision Diagnosis and Treatment Solution

Selected research

Industry Growth & Trends

Global Integrated Precision Diagnosis and Treatment Solution Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Integrated Precision Diagnosis and Treatment Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Integrated Precision Diagnosis and Treatment Solution market include Illumina, QIAGEN, Caris Life Sciences, Foundation Medicine, Guardant Health, NeoGenomics, Myriad Genetics, Thermo Fisher Scientific and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Integrated Precision Diagnosis and Treatment Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Integrated Precision Diagnosis and Treatment Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Integrated Precision Diagnosis and Treatment Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Integrated Precision Diagnosis and Treatment Solution.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Integrated Precision Diagnosis and Treatment Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Integrated Precision Diagnosis and Treatment Solution Market by Company

Illumina

QIAGEN

Caris Life Sciences

Foundation Medicine

Guardant Health

NeoGenomics

Myriad Genetics

Thermo Fisher Scientific

Roche Holding AG

Abbott Laboratories

GE HealthCare

Tempus Labs

Personalis

Genome Medical

Endeavor Biomedicines

Integrated Precision Diagnosis and Treatment Solution Segment by Type

Genomics

Proteomics

Metabolomics

Radiomics

Integrated Precision Diagnosis and Treatment Solution Segment by Application

Medical Institutions

Research and Academic Institutions

Integrated Precision Diagnosis and Treatment Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Precision Diagnosis and Treatment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrated Precision Diagnosis and Treatment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Precision Diagnosis and Treatment Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Integrated Precision Diagnosis and Treatment Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Integrated Precision Diagnosis and Treatment Solution Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Region (2021-2026) Table 4. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Region (2027-2032) Table 6. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Integrated Precision Diagnosis and Treatment Solution Market Size Share by Type (2021-2026) Table 9. Global Integrated Precision Diagnosis and Treatment Solution Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Integrated Precision Diagnosis and Treatment Solution Market Size Share Forecasted by Type (2027-2032) Table 11. North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Integrated Precision Diagnosis and Treatment Solution Market Size Share by Application (2021-2026) Table 24. Global Integrated Precision Diagnosis and Treatment Solution Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Integrated Precision Diagnosis and Treatment Solution Market Size Share Forecasted by Application (2027-2032) Table 26. North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Integrated Precision Diagnosis and Treatment Solution Industry Trends Table 37. Integrated Precision Diagnosis and Treatment Solution Industry Drivers Table 38. Integrated Precision Diagnosis and Treatment Solution Industry Opportunities and Challenges Table 39. Integrated Precision Diagnosis and Treatment Solution Industry Restraints Table 40. Global Integrated Precision Diagnosis and Treatment Solution Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Integrated Precision Diagnosis and Treatment Solution Revenue Market Share by Company (2021-2026) Table 42. Global Integrated Precision Diagnosis and Treatment Solution Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Integrated Precision Diagnosis and Treatment Solution Key Company Headquarters & Area Served Table 44. Global Integrated Precision Diagnosis and Treatment Solution Company, Product Type & Application Table 45. Global Integrated Precision Diagnosis and Treatment Solution Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Integrated Precision Diagnosis and Treatment Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Illumina Company Information Table 49. Illumina Business Overview Table 50. Illumina Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Illumina Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 52. Illumina Recent Development Table 53. QIAGEN Company Information Table 54. QIAGEN Business Overview Table 55. QIAGEN Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. QIAGEN Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 57. QIAGEN Recent Development Table 58. Caris Life Sciences Company Information Table 59. Caris Life Sciences Business Overview Table 60. Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 62. Caris Life Sciences Recent Development Table 63. Foundation Medicine Company Information Table 64. Foundation Medicine Business Overview Table 65. Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 67. Foundation Medicine Recent Development Table 68. Guardant Health Company Information Table 69. Guardant Health Business Overview Table 70. Guardant Health Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Guardant Health Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 72. Guardant Health Recent Development Table 73. NeoGenomics Company Information Table 74. NeoGenomics Business Overview Table 75. NeoGenomics Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. NeoGenomics Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 77. NeoGenomics Recent Development Table 78. Myriad Genetics Company Information Table 79. Myriad Genetics Business Overview Table 80. Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 82. Myriad Genetics Recent Development Table 83. Thermo Fisher Scientific Company Information Table 84. Thermo Fisher Scientific Business Overview Table 85. Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 87. Thermo Fisher Scientific Recent Development Table 88. Roche Holding AG Company Information Table 89. Roche Holding AG Business Overview Table 90. Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 92. Roche Holding AG Recent Development Table 93. Abbott Laboratories Company Information Table 94. Abbott Laboratories Business Overview Table 95. Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 97. Abbott Laboratories Recent Development Table 98. GE HealthCare Company Information Table 99. GE HealthCare Business Overview Table 100. GE HealthCare Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GE HealthCare Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 102. GE HealthCare Recent Development Table 103. Tempus Labs Company Information Table 104. Tempus Labs Business Overview Table 105. Tempus Labs Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Tempus Labs Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 107. Tempus Labs Recent Development Table 108. Personalis Company Information Table 109. Personalis Business Overview Table 110. Personalis Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Personalis Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 112. Personalis Recent Development Table 113. Genome Medical Company Information Table 114. Genome Medical Business Overview Table 115. Genome Medical Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Genome Medical Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 117. Genome Medical Recent Development Table 118. Endeavor Biomedicines Company Information Table 119. Endeavor Biomedicines Business Overview Table 120. Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Product Portfolio Table 122. Endeavor Biomedicines Recent Development Table 123. North America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2026) Table 126. North America Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Integrated Precision Diagnosis and Treatment Solution Market Share Forecast by Country (2027-2032) Table 128. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2026) Table 131. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Integrated Precision Diagnosis and Treatment Solution Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2026) Table 136. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Share Forecast by Country (2027-2032) Table 138. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2026) Table 141. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Integrated Precision Diagnosis and Treatment Solution Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2026) Table 146. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Integrated Precision Diagnosis and Treatment Solution Product Image Figure 3. Global Integrated Precision Diagnosis and Treatment Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032) & (US$ Million) Figure 5. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Region: 2025 VS 2032 Figure 6. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Region (2021-2032) Figure 7. North America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Genomics Image Figure 13. Global Genomics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Proteomics Image Figure 15. Global Proteomics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Metabolomics Image Figure 17. Global Metabolomics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Radiomics Image Figure 19. Global Radiomics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Type 2025 VS 2032 Figure 22. North America Integrated Precision Diagnosis and Treatment Solution Market Size Share by Type (2021-2032) Figure 23. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Share by Type (2021-2032) Figure 25. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Share by Type (2021-2032) Figure 27. Medical Institutions Image Figure 28. Global Medical Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Research and Academic Institutions Image Figure 30. Global Research and Academic Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Application 2025 VS 2032 Figure 33. North America Integrated Precision Diagnosis and Treatment Solution Market Size Share by Application (2021-2032) Figure 34. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Share by Application (2021-2032) Figure 36. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Integrated Precision Diagnosis and Treatment Solution Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Integrated Precision Diagnosis and Treatment Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2032) Figure 43. Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Integrated Precision Diagnosis and Treatment Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2032) Figure 46. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2032) Figure 49. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Integrated Precision Diagnosis and Treatment Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2032) Figure 52. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Genomics
  • Proteomics
  • Metabolomics
  • Radiomics
Applications
  • Medical Institutions
  • Research and Academic Institutions
Companies covered
  • Illumina
  • QIAGEN
  • Caris Life Sciences
  • Foundation Medicine
  • Guardant Health
  • NeoGenomics
  • Myriad Genetics
  • Thermo Fisher Scientific
  • Roche Holding AG
  • Abbott Laboratories
  • GE HealthCare
  • Tempus Labs
  • Personalis
  • Genome Medical
  • Endeavor Biomedicines

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2021-2032)
  5. 1.4.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2021-2026)
  6. 1.4.2 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2027-2032)
  7. 1.5 Key Regions Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
  8. 1.5.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
2 Integrated Precision Diagnosis and Treatment Solution Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Genomics
  3. 2.1.2 Proteomics
  4. 2.1.3 Metabolomics
  5. 2.1.4 Radiomics
  6. 2.2 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Type
  7. 2.2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Regions
  11. 2.3.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
3 Integrated Precision Diagnosis and Treatment Solution Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Institutions
  3. 3.1.2 Research and Academic Institutions
  4. 3.2 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Application
  5. 3.2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Regions
  9. 3.3.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Integrated Precision Diagnosis and Treatment Solution Industry Trends
  2. 4.2 Integrated Precision Diagnosis and Treatment Solution Industry Drivers
  3. 4.3 Integrated Precision Diagnosis and Treatment Solution Industry Opportunities and Challenges
  4. 4.4 Integrated Precision Diagnosis and Treatment Solution Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Integrated Precision Diagnosis and Treatment Solution Revenue (2021-2026)
  2. 5.2 Global Integrated Precision Diagnosis and Treatment Solution Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Integrated Precision Diagnosis and Treatment Solution Key Company Headquarters & Area Served
  4. 5.4 Global Integrated Precision Diagnosis and Treatment Solution Company, Product Type & Application
  5. 5.5 Global Integrated Precision Diagnosis and Treatment Solution Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Integrated Precision Diagnosis and Treatment Solution Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Integrated Precision Diagnosis and Treatment Solution Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Integrated Precision Diagnosis and Treatment Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Illumina Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 QIAGEN
  8. 6.2.1 QIAGEN Company Information
  9. 6.2.2 QIAGEN Business Overview
  10. 6.2.3 QIAGEN Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 QIAGEN Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  12. 6.2.5 QIAGEN Recent Developments
  13. 6.3 Caris Life Sciences
  14. 6.3.1 Caris Life Sciences Company Information
  15. 6.3.2 Caris Life Sciences Business Overview
  16. 6.3.3 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  18. 6.3.5 Caris Life Sciences Recent Developments
  19. 6.4 Foundation Medicine
  20. 6.4.1 Foundation Medicine Company Information
  21. 6.4.2 Foundation Medicine Business Overview
  22. 6.4.3 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  24. 6.4.5 Foundation Medicine Recent Developments
  25. 6.5 Guardant Health
  26. 6.5.1 Guardant Health Company Information
  27. 6.5.2 Guardant Health Business Overview
  28. 6.5.3 Guardant Health Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Guardant Health Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  30. 6.5.5 Guardant Health Recent Developments
  31. 6.6 NeoGenomics
  32. 6.6.1 NeoGenomics Company Information
  33. 6.6.2 NeoGenomics Business Overview
  34. 6.6.3 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  36. 6.6.5 NeoGenomics Recent Developments
  37. 6.7 Myriad Genetics
  38. 6.7.1 Myriad Genetics Company Information
  39. 6.7.2 Myriad Genetics Business Overview
  40. 6.7.3 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  42. 6.7.5 Myriad Genetics Recent Developments
  43. 6.8 Thermo Fisher Scientific
  44. 6.8.1 Thermo Fisher Scientific Company Information
  45. 6.8.2 Thermo Fisher Scientific Business Overview
  46. 6.8.3 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  48. 6.8.5 Thermo Fisher Scientific Recent Developments
  49. 6.9 Roche Holding AG
  50. 6.9.1 Roche Holding AG Company Information
  51. 6.9.2 Roche Holding AG Business Overview
  52. 6.9.3 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  54. 6.9.5 Roche Holding AG Recent Developments
  55. 6.10 Abbott Laboratories
  56. 6.10.1 Abbott Laboratories Company Information
  57. 6.10.2 Abbott Laboratories Business Overview
  58. 6.10.3 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  60. 6.10.5 Abbott Laboratories Recent Developments
  61. 6.11 GE HealthCare
  62. 6.11.1 GE HealthCare Company Information
  63. 6.11.2 GE HealthCare Business Overview
  64. 6.11.3 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  66. 6.11.5 GE HealthCare Recent Developments
  67. 6.12 Tempus Labs
  68. 6.12.1 Tempus Labs Company Information
  69. 6.12.2 Tempus Labs Business Overview
  70. 6.12.3 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  72. 6.12.5 Tempus Labs Recent Developments
  73. 6.13 Personalis
  74. 6.13.1 Personalis Company Information
  75. 6.13.2 Personalis Business Overview
  76. 6.13.3 Personalis Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Personalis Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  78. 6.13.5 Personalis Recent Developments
  79. 6.14 Genome Medical
  80. 6.14.1 Genome Medical Company Information
  81. 6.14.2 Genome Medical Business Overview
  82. 6.14.3 Genome Medical Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Genome Medical Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  84. 6.14.5 Genome Medical Recent Developments
  85. 6.15 Endeavor Biomedicines
  86. 6.15.1 Endeavor Biomedicines Company Information
  87. 6.15.2 Endeavor Biomedicines Business Overview
  88. 6.15.3 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Product Portfolio
  90. 6.15.5 Endeavor Biomedicines Recent Developments
7 North America
  1. 7.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
  3. 7.3 North America Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
  3. 8.3 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
  3. 10.3 South America Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.